We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

I Understand

Drug Discovery

from TECHNOLOGY NETWORKS

Pathway independent cell-based assays on the EnSpire Multimode Plate Reader with Epic® label-free technology

Application Note Feb 22, 2011

PerkinElmer

GPCRs constitute one of the largest classes of therapeutic targets within drug discovery. By successfully monitoring the ligand-induced dynamic mass redistribution (DMR) in living cells, this application note demonstrates that this label-free technology is a comprehensive and versatile tool for GPCR research enabling the generation of physiologically-relevant data.

VIEW APPLICATION NOTE

RELATED APPLICATION NOTES

Multiomic Profiling of the Immune System at Single-Cell Resolution

Application Note

Traditional methods of immune surveillance allow researchers to interrogate one data type at a time, leaving them with an incomplete understanding of the immune response. In order to characterize the immune response, the ability to phenotype individual cells with multiple parameters and at massive scale is necessary.

High-Performance CQA Analysis in Biopharma

Application Note

Download this application compendium to discover an ultra-high performance liquid chromatography approach for refined charge variant analysis of mAbs, elevated mAb aggregate analysis and HIC analysis of drug-to-antibody ratio with high salt concentrations.

Cell-Free Protein Expression Using Twist Gene Fragments

Application Note

A cornerstone of synthetic biology is designing DNA sequences and testing the characteristics and functions of the resultant proteins. Traditional in vivo protein expression workflows can be time-intensive and laborious, and they can fail if the protein is toxic to the host cells.

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free